The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.
Read More
With so many weight loss medications on the market, it’s hard to know which to choose. Dr. Khorassani tells us everything we need to know to about selecting and prescribing these agents. Also, she gives us additional tips for managing antipsychotic-induced weight gain.
Read More
We can use our knowledge of gender differences in schizophrenia, argues Dr. Kulkarni, to inform and broaden our interventions for female patients.
Read More
Dr. Hendrick is a clinical professor at the David Geffen School of Medicine at UCLA and is the director of inpatient psychiatry at Olive View—UCLA Medical Center, where she carries a caseload of patients and provides teaching and supervision for medical students and psychiatry residents. After completing medical school and psychiatric residency at UCLA, she spent several years working as a principal investigator and co-investigator on N.I.M.H. funded research studies. She has authored or co-authored over 75 research papers, editorials, books and other publications. She has a long-standing interest in the needs of severely mentally ill patients from underserved populations and has worked in community mental health settings her entire career.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
